Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential
Divya Gupta, Haripriya Parthasarathy, Vishal Sah, Dixit Tandel, Dhiviya Vedagiri, Shashikala Reddy, Krishnan Harinivas Harshan
Topics & Concepts
VirologyAntiserumBiologyAntigenVirusCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MicrobiologyImmunologyInfectious disease (medical specialty)DiseaseMedicinePathologySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingBiosensors and Analytical Detection